HomeInsightsPB

Remus Pharmaceuticals Ltd PB Ratio

Remus Pharmaceuticals Ltd PB Ratio

stocks purchased

₹ 0.5 Cr

Volume Transacted

()

stocks purchased

2.1 K

Stocks Traded

()

Last Updated on: Nov 08, 2024

Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PB

16.8

Last updated on: Nov 07, 2024

Key Highlights

  • The P/B Ratio of Remus Pharmaceuticals Ltd is 16.8 as of 07 Nov 24.
  • The P/B Ratio of Remus Pharmaceuticals Ltd is 11.7 as of March 2024.
Image

Remus Pharmaceuticals Ltd

NSE: RemusPharma.

PB

11.7

Last updated on: Invalid Date

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Remus Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20242480
06 Nov 20242529.45
05 Nov 20242544.55
04 Nov 20242542.6
01 Nov 20242632.3
31 Oct 20242616.7
30 Oct 20242598.75
29 Oct 20242571.45
28 Oct 20242441
25 Oct 20242404.75

SWOT Analysis Of Remus Pharmaceuticals Ltd

Strength

4

S

Weakness

3

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Remus Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Remus Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Key Valuation Metric of Remus Pharmaceuticals Ltd

No data available

No data available

Historical Market Cap of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical EBITDA of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Net Profit of Remus Pharmaceuticals Ltd

No data available

* All values are in crore

Dividend Payout Over Time

No data available

Remus Pharmaceuticals Ltd News Hub

News

Remus Pharmaceuticals to convene board meeting

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 9 No...

Read more

07 Nov 202410:21

News

Remus Pharmaceuticals to convene AGM

Remus Pharmaceuticals announced that the 9th Annual General Meeting (AGM) of the company w...

Read more

31 Aug 202415:40

News

Remus Pharmaceuticals to table results

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 16 M...

Read more

10 May 202412:07

News

Remus Pharmaceuticals schedules EGM

Remus Pharmaceuticals announced that an Extra Ordinary General Meeting (EGM) of the Compan...

Read more

24 Apr 202410:34

News

Remus Pharmaceuticals revises board meeting date

Remus Pharmaceuticals has revised the meeting of the Board of Directors which was schedule...

Read more

20 Apr 202415:16

News

Remus Pharmaceuticals to consider Dividend

Remus Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 A...

Read more

17 Apr 202409:39

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PB Ratio of Remus Pharmaceuticals Ltd

What is the PB ratio of Remus Pharmaceuticals Ltd?

The current PB ratio of Remus Pharmaceuticals Ltd is 0.0. The Price-to-Book value (P/B) ratio compares a company's current share price to its book value per share. It helps assess whether a stock is overvalued or undervalued relative to its net asset value.

What is the ideal PB ratio to buy Remus Pharmaceuticals Ltd stocks?

An ideal PB ratio varies by industry; however, a PB ratio below 1.0 may indicate a good buying opportunity for Remus Pharmaceuticals Ltd. Some investors and financial analysts may also consider any value under 3.0 as a good PB ratio.

How is the PB Ratio of Remus Pharmaceuticals Ltd calculated?

The PB ratio of Remus Pharmaceuticals Ltd is calculated by dividing the current share price by the book value per share. The book value per share is determined by dividing the company’s total net assets (assets minus liabilities) by the number of outstanding shares. This ratio helps evaluate how the market values the company's assets.

What does a high PB Ratio mean for Remus Pharmaceuticals Ltd?

A high PB ratio suggests that Remus Pharmaceuticals Ltd’s stock may be overvalued relative to its book value or that investors expect high growth.

What does a low PB Ratio indicate for Remus Pharmaceuticals Ltd?

A low PB ratio of Remus Pharmaceuticals Ltd may indicate that the stock is undervalued or it is facing financial difficulties.

Can Remus Pharmaceuticals Ltd PB Ratio change over time?

Yes, the PB ratio of Remus Pharmaceuticals Ltd can change over time due to fluctuations in the company’s stock price and changes in its book value.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*